Consolidated Balance Sheets $ in Thousands	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Current assets:
Cash and cash equivalents	$ 98,716	$ 167,299
Restricted cash	29	331
Marketable securities	179,145	95,111
Trade accounts receivable, net	60,588	55,928
Inventories	43,893	60,877
Prepaid expenses and other current assets	14,075	12,514
Total current assets	396,446	392,060
Deferred income tax assets, noncurrent	33,374	30,487
Property and equipment, net	17,962	18,405
Operating lease right-of-use assets	10,168	10,853
Goodwill	16,663	16,183
Intangible assets, net	20,128	23,084
Other noncurrent assets	4,759	3,385
Total assets	499,500	494,457
Current liabilities:
Trade accounts payable	5,529	3,032
Legal settlement liability, current	1,705	2,561
Accrued expenses	21,443	20,035
Other current liabilities	13,494	7,903
Deferred revenue, current	25,492	22,695
Total current liabilities	67,663	56,226
Legal settlement liability, noncurrent	9,036	16,477
Deferred revenue, noncurrent	16,098	15,132
Operating lease liability, noncurrent	7,552	9,479
Long term debt	1,050	1,648
Other noncurrent liabilities	2,364	2,431
Total liabilities	103,763	101,393
Commitments and contingencies (Note 18)
Stockholders’ equity:
Common stock, $0.001 par value; 1,000,000,000 authorized shares as of December 31, 2024 and December 31, 2023, respectively; 129,205,901 and 130,714,906 issued and outstanding shares as of December 31, 2024 and December 31, 2023, respectively.	129	131
Additional paid-in capital	430,791	423,386
Accumulated deficit	(35,199)	(29,178)
Accumulated other comprehensive gain (loss)	16	(1,275)
Total stockholders’ equity	395,737	393,064
Total liabilities and stockholders’ equity	$ 499,500	$ 494,457